test-section

Learn More

Learn more about future Onkure Clinical Trials

Press Releases

06/11/2019

OnKure and CU Cancer Center announce first patient enrolled in clinical trial of OKI-179

05/06/2019

OnKure Announces FDA IND Regulatory Clearance to Start Phase 1 Trials for OKI-179

05/02/2018

OnKure Close $7M Series A Financing to Support Development of Epigenetics Drug

our-philosophy-is

There are several lines of evidence suggesting the important role of epigenetics in cancer, including the fact that all cancers show epigenetic change, and most cancer mutations affect the epigenome.

Andrew Feinberg from the Johns Hopkins School of Medicine Center for Epigenetics in Baltimore, Maryland